Abdullah Erdem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abdullah Erdem has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Şule Acar Duyan
Selcuk Universitesi
4 shared publications - Ayşe Bozkurt Oflaz
Selcuk Universitesi
3 shared publications - Abdullah Beyoğlu
Department of Ophthalmology, Selcuk University, Konya 42130, Türkiye
2 shared publications Şaban Gönül
2 shared publicationsAyşe Bozkurt Oflaz
1 shared publication- Banu Turgut Ozturk
Department of Ophthalmology, Faculty of Medicine, Selcuk University, Konya, Turkey
1 shared publication
Latest Publications
- Open Access
- 26 August 2026
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 56 (4) , 283-286
Coexistence of Retinitis Pigmentosa and Coats-Like Vitreoretinopathy
Coexistence of Retinitis Pigmentosa and Coats-Like Vitreoretinopathy - Turkish Journal of Ophthalmology
- 26 August 2026
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 56 (4) , 283-286
Open AccessCoexistence of Retinitis Pigmentosa and Coats-Like Vitreoretinopathy
Coexistence of Retinitis Pigmentosa and Coats-Like Vitreoretinopathy - Turkish Journal of Ophthalmology
- 9 April 2026
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1) , 199
Evaluation of the triglyceride-glucose index, serum inflammatory biomarkers and lipid profile in patients with neovascular age-related macular degeneration
Purpose To evaluate the triglyceride–glucose index (TyG), novel systemic inflammatory biomarkers, and lipid profile in patients with neovascular age-related macular degeneration (nAMD), and to investigate their potential relationship with disease presence. Methods This retrospective case–control study included 59 patients diagnosed with nAMD and 67 age- and sex-matched healthy controls. Demographic characteristics, fasting biochemical tests, lipid profile, complete blood count, and serum inflammatory indices were recorded. Triglyceride–glucose index, systemic inflammatory indices derived from various hematological parameters and lipid levels were calculated. Laboratory parameters and calculated indexes were compared between the two groups using Statistical Package for the Social Sciences (SPSS). Results Triglyceride–glucose index was significantly higher in the nAMD group than in controls (4.84 ± 0.27 vs. 4.69 ± 0.17, p = 0.0001). Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) levels were also elevated in the nAMD group (p = 0.0001 for both). Among hematological markers, white blood count (WBC), neutrophil, and monocyte counts were significantly increased in nAMD patients (p = 0.012, p = 0.001, p = 0.015, respectively). Inflammatory indices including neutrophil/lymphocyte ratio (NLR) (p = 0.015), monocyte/HDL-C ratio (MHR) (p = 0.003), systemic inflammation aggregate index (AISI) (p = 0.025), and C reactive protein/albumine ratio (CAR) (p = 0.006) were significantly higher in the nAMD group, whereas the systemic immune inflammation index (SII), platelet/lymphocyte ratio (PLR) and monocyte/lymphocyte ratio (MLR) showed no significant differences (p > 0.05). Serum lipid levels and atherogenic lipid ratios did not differ between the groups. Discussion Patients with nAMD exhibit increased systemic inflammatory activity and metabolic stress, reflected by elevated NLR, MHR, AISI, and CAR levels. In addition, TyG, a novel indicator of systemic insulin resistance, was found to be elevated in nAMD patients. These findings suggest that metabolic dysregulation and chronic low-grade systemic inflammation may contribute to nAMD pathogenesis independently of serum lipid levels. The TyG and inflammation-derived biomarkers may serve as potential systemic indicators for nAMD risk or disease activity.
- 9 April 2026
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1) , 199
Evaluation of the triglyceride-glucose index, serum inflammatory biomarkers and lipid profile in patients with neovascular age-related macular degeneration
Purpose To evaluate the triglyceride–glucose index (TyG), novel systemic inflammatory biomarkers, and lipid profile in patients with neovascular age-related macular degeneration (nAMD), and to investigate their potential relationship with disease presence. Methods This retrospective case–control study included 59 patients diagnosed with nAMD and 67 age- and sex-matched healthy controls. Demographic characteristics, fasting biochemical tests, lipid profile, complete blood count, and serum inflammatory indices were recorded. Triglyceride–glucose index, systemic inflammatory indices derived from various hematological parameters and lipid levels were calculated. Laboratory parameters and calculated indexes were compared between the two groups using Statistical Package for the Social Sciences (SPSS). Results Triglyceride–glucose index was significantly higher in the nAMD group than in controls (4.84 ± 0.27 vs. 4.69 ± 0.17, p = 0.0001). Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) levels were also elevated in the nAMD group (p = 0.0001 for both). Among hematological markers, white blood count (WBC), neutrophil, and monocyte counts were significantly increased in nAMD patients (p = 0.012, p = 0.001, p = 0.015, respectively). Inflammatory indices including neutrophil/lymphocyte ratio (NLR) (p = 0.015), monocyte/HDL-C ratio (MHR) (p = 0.003), systemic inflammation aggregate index (AISI) (p = 0.025), and C reactive protein/albumine ratio (CAR) (p = 0.006) were significantly higher in the nAMD group, whereas the systemic immune inflammation index (SII), platelet/lymphocyte ratio (PLR) and monocyte/lymphocyte ratio (MLR) showed no significant differences (p > 0.05). Serum lipid levels and atherogenic lipid ratios did not differ between the groups. Discussion Patients with nAMD exhibit increased systemic inflammatory activity and metabolic stress, reflected by elevated NLR, MHR, AISI, and CAR levels. In addition, TyG, a novel indicator of systemic insulin resistance, was found to be elevated in nAMD patients. These findings suggest that metabolic dysregulation and chronic low-grade systemic inflammation may contribute to nAMD pathogenesis independently of serum lipid levels. The TyG and inflammation-derived biomarkers may serve as potential systemic indicators for nAMD risk or disease activity.
- 25 March 2026
- Published by Gumushane University in Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 15 (1) , 148-156
A Study on Accuracy and Readability of Frequently Asked Questions in Corneal Transplantation: Cross-Linguistic Evaluation of Large Language Models in Ophthalmic Patient Communication
This study assessed the accuracy, relevance, and readability of large language models (LLMs) in answering frequently asked questions (FAQs) on corneal transplantation. ChatGPT-3.5, ChatGPT 4o, Gemini, Copilot, and DeepSeek were evaluated using responses to 10 FAQs in Turkish and English. Accuracy was independently rated by two ophthalmologists, while readability was measured using the Ateşman and Çetinkaya indices for Turkish and six established English indices. Response length was analyzed by character, word, and sentence counts. The proportions of “correct and complete” responses were 72% for ChatGPT-3.5, 80% for ChatGPT 4o, 76% for Gemini, 70% for Copilot, and 71% for DeepSeek (p=0.47). In Turkish, Copilot produced the most complex texts, whereas DeepSeek achieved the highest readability based on the Ateşman index (58.2); according to the Çetinkaya index, ChatGPT 4o had the highest Turkish readability score (19.98). In English, DeepSeek demonstrated the highest readability across indices, while Gemini consistently generated the most complex outputs. Response length differed significantly between Turkish and English (p<0.001). Overall, LLMs provided largely accurate responses to patient-oriented corneal transplantation queries; however, variability in readability across languages indicates limitations in cross-linguistic communication. Enhancing linguistic adaptability and content accuracy remains essential for multilingual medical applications.
- 25 March 2026
- Published by Gumushane University in Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 15 (1) , 148-156
A Study on Accuracy and Readability of Frequently Asked Questions in Corneal Transplantation: Cross-Linguistic Evaluation of Large Language Models in Ophthalmic Patient Communication
This study assessed the accuracy, relevance, and readability of large language models (LLMs) in answering frequently asked questions (FAQs) on corneal transplantation. ChatGPT-3.5, ChatGPT 4o, Gemini, Copilot, and DeepSeek were evaluated using responses to 10 FAQs in Turkish and English. Accuracy was independently rated by two ophthalmologists, while readability was measured using the Ateşman and Çetinkaya indices for Turkish and six established English indices. Response length was analyzed by character, word, and sentence counts. The proportions of “correct and complete” responses were 72% for ChatGPT-3.5, 80% for ChatGPT 4o, 76% for Gemini, 70% for Copilot, and 71% for DeepSeek (p=0.47). In Turkish, Copilot produced the most complex texts, whereas DeepSeek achieved the highest readability based on the Ateşman index (58.2); according to the Çetinkaya index, ChatGPT 4o had the highest Turkish readability score (19.98). In English, DeepSeek demonstrated the highest readability across indices, while Gemini consistently generated the most complex outputs. Response length differed significantly between Turkish and English (p<0.001). Overall, LLMs provided largely accurate responses to patient-oriented corneal transplantation queries; however, variability in readability across languages indicates limitations in cross-linguistic communication. Enhancing linguistic adaptability and content accuracy remains essential for multilingual medical applications.
- 1 January 2026
- Published by Gazi Goz Vakfi in Journal of Retina-Vitreous
- Vol. 35 (1) , 59
Retinal microvascular changes in euthyroid graves' disease without ocular involvement using optical coherence tomography angiography
- 1 January 2026
- Published by Gazi Goz Vakfi in Journal of Retina-Vitreous
- Vol. 35 (1) , 59
Retinal microvascular changes in euthyroid graves' disease without ocular involvement using optical coherence tomography angiography
- Open Access
- 2 November 2025
- Published by MediHealth Academy in Güncel Retina Dergisi (Current Retina Journal)
- Vol. 10 (4) , 348-350
Juvenile X-Linked Retinoschisis: Ocular Genetic Studies
Juvenile X-linked retinoschisis (JXLR, OMIM 312700) is an inherited retinal disorder characterized by X-linked inheritance, primarily affecting males and leading to severe vision loss starting in childhood. The diagnosis is established through characteristic clinical findings, imaging features, and genetic analysis. Although there is no definitive cure, both medical and surgical treatment options are used with varying degrees of benefit. The lack of a curative treatment has prompted the exploration of gene therapy. Currently, there is no approved gene therapy available, but numerous clinical trials are ongoing.
- 2 November 2025
- Published by MediHealth Academy in Güncel Retina Dergisi (Current Retina Journal)
- Vol. 10 (4) , 348-350
Open AccessJuvenile X-Linked Retinoschisis: Ocular Genetic Studies
Juvenile X-linked retinoschisis (JXLR, OMIM 312700) is an inherited retinal disorder characterized by X-linked inheritance, primarily affecting males and leading to severe vision loss starting in childhood. The diagnosis is established through characteristic clinical findings, imaging features, and genetic analysis. Although there is no definitive cure, both medical and surgical treatment options are used with varying degrees of benefit. The lack of a curative treatment has prompted the exploration of gene therapy. Currently, there is no approved gene therapy available, but numerous clinical trials are ongoing.
- Open Access
Optical Coherence Tomography Biomarkers Predict the Long-Term Restorative Effect of Early Anti-VEGF Treatment on Diabetic Macular Edema
Background/Purpose: This study compared the effects of three induction doses of anti-vascular endothelial growth factor (anti-VEGF) on diabetic macular edema (DME) with that of long-term treatment using biomarkers to find out the predictability potential of early response to anti-VEGF treatment for the long-term restorative effect. Methods: We retrospectively reviewed the clinical and optical coherence tomography (OCT) data of 71 DME eyes treated with three monthly anti-VEGF doses and followed for 1 year. BCVA, central subfield thickness (CST), subretinal fluid (SRF), intraretinal cysts, hyperreflective foci (HF), disorganization of inner retinal layers (DRILs), ellipsoid zone/external limiting membrane (EZ/ELM) integrity, and vitreoretinal relationships were assessed at baseline, 3, 6, and 12 months. Results: Patients (50.7% male) had a mean follow-up of 12 months. After three anti-VEGF doses, 19 eyes required no additional injections, 25 continued anti-VEGF, 20 switched to dexamethasone implants, and seven received combination therapy. Best corrected visual acuity (BCVA) improved from 0.52 to 0.40 logMAR at 3 months, 0.30 at 6 months, and stabilized at 0.40 at 12 months. CST decreased from 406 µm to 317 µm at 3 months and 307 µm at 12 months. Significant early improvements in BCVA, CST, SRF, and intraretinal cysts were sustained in the long-term follow-up. HF reduction became significant after 6 months, while DRIL and EZ/ELM integrity remained unchanged. Conclusions: The improvement of OCT biomarkers in DME patients supported that intravitreal anti-VEGF significantly restored the retinal microstructure, which was already evident at 3 months in the control after anti-VEGF induction.
Open AccessOptical Coherence Tomography Biomarkers Predict the Long-Term Restorative Effect of Early Anti-VEGF Treatment on Diabetic Macular Edema
Background/Purpose: This study compared the effects of three induction doses of anti-vascular endothelial growth factor (anti-VEGF) on diabetic macular edema (DME) with that of long-term treatment using biomarkers to find out the predictability potential of early response to anti-VEGF treatment for the long-term restorative effect. Methods: We retrospectively reviewed the clinical and optical coherence tomography (OCT) data of 71 DME eyes treated with three monthly anti-VEGF doses and followed for 1 year. BCVA, central subfield thickness (CST), subretinal fluid (SRF), intraretinal cysts, hyperreflective foci (HF), disorganization of inner retinal layers (DRILs), ellipsoid zone/external limiting membrane (EZ/ELM) integrity, and vitreoretinal relationships were assessed at baseline, 3, 6, and 12 months. Results: Patients (50.7% male) had a mean follow-up of 12 months. After three anti-VEGF doses, 19 eyes required no additional injections, 25 continued anti-VEGF, 20 switched to dexamethasone implants, and seven received combination therapy. Best corrected visual acuity (BCVA) improved from 0.52 to 0.40 logMAR at 3 months, 0.30 at 6 months, and stabilized at 0.40 at 12 months. CST decreased from 406 µm to 317 µm at 3 months and 307 µm at 12 months. Significant early improvements in BCVA, CST, SRF, and intraretinal cysts were sustained in the long-term follow-up. HF reduction became significant after 6 months, while DRIL and EZ/ELM integrity remained unchanged. Conclusions: The improvement of OCT biomarkers in DME patients supported that intravitreal anti-VEGF significantly restored the retinal microstructure, which was already evident at 3 months in the control after anti-VEGF induction.
- Open Access
- 6 January 2025
- Published by MediHealth Academy in Ankyra Medical Journal
- Vol. 4 (1) , 9-13
Stem cell therapies in ophthalmology
Stem cells have been used for therapeutic purposes in many areas of medicine for many years. Depending on the tissues from which they are derived and their characteristics, stem cells can be classified into various groups. Some types of stem cells have the capacity to form an entire organism, while others can only differentiate into certain groups of tissues. In recent years, stem cells have also become popular in ophthalmology. Both stem cells found in ocular tissues and those derived from peripheral tissues are gaining attention for their use in ophthalmology. In ophthalmology, stem cells have a wide range of applications, from ocular surface and periocular tissue applications to retinal diseases. Some applications, such as limbal stem cell transplantation, have become common practices in clinical settings, while experimental and promising stem cell methods, such as anterior chamber stem cell transplants or subretinal supracoroidal stem cell transplants, are being investigated. Stem cells offer hope in ophthalmology for diseases that are unresponsive to traditional treatments, irreversible diseases, or dystrophic diseases that still lack approved treatments. The long-term effects of stem cell transplants in ophthalmology have not been clearly established, and the potential for tumor development due to uncontrolled proliferation has not been entirely eliminated. While there is a possibility of negative results from experimental studies and the emergence of concerning side effects, stem cells still hold promise as an alternative treatment option in ophthalmology.
- 6 January 2025
- Published by MediHealth Academy in Ankyra Medical Journal
- Vol. 4 (1) , 9-13
Open AccessStem cell therapies in ophthalmology
Stem cells have been used for therapeutic purposes in many areas of medicine for many years. Depending on the tissues from which they are derived and their characteristics, stem cells can be classified into various groups. Some types of stem cells have the capacity to form an entire organism, while others can only differentiate into certain groups of tissues. In recent years, stem cells have also become popular in ophthalmology. Both stem cells found in ocular tissues and those derived from peripheral tissues are gaining attention for their use in ophthalmology. In ophthalmology, stem cells have a wide range of applications, from ocular surface and periocular tissue applications to retinal diseases. Some applications, such as limbal stem cell transplantation, have become common practices in clinical settings, while experimental and promising stem cell methods, such as anterior chamber stem cell transplants or subretinal supracoroidal stem cell transplants, are being investigated. Stem cells offer hope in ophthalmology for diseases that are unresponsive to traditional treatments, irreversible diseases, or dystrophic diseases that still lack approved treatments. The long-term effects of stem cell transplants in ophthalmology have not been clearly established, and the potential for tumor development due to uncontrolled proliferation has not been entirely eliminated. While there is a possibility of negative results from experimental studies and the emergence of concerning side effects, stem cells still hold promise as an alternative treatment option in ophthalmology.
- Open Access
- 1 January 2025
- Published by Kare Publishing in Beyoglu Eye Journal
- Vol. 10 (4) , 254-257
Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Case-Based Differential Diagnosis
Tamoxifen is a widely used agent for the treatment of breast cancer worldwide. Despite its significant efficacy in breast cancer, serious side effects may occur with long-term or high-dose use. One of these side effects is tamoxifen retinopathy (TR). Tamoxifen retinopathy typically presents with bilateral visual impairment, crystalline deposits, and changes in the foveal reflex during fundus examination. Although characteristic features can be observed with multimodal imaging, it may be confused with various retinal pathologies. One of the primary conditions considered in the differential diagnosis of TR is macular telangiectasia type 2 (Mac-Tel 2). In this case presentation, we aim to share the differential diagnosis process of TR and highlight the distinguishing features from Mac-Tel 2 in a female patient who presented with decreased vision, based on the patient’s history, detailed fundoscopic examination findings, and multimodal imaging.
- 1 January 2025
- Published by Kare Publishing in Beyoglu Eye Journal
- Vol. 10 (4) , 254-257
Open AccessTamoxifen Retinopathy and Macular Telangiectasia Type 2: Case-Based Differential Diagnosis
Tamoxifen is a widely used agent for the treatment of breast cancer worldwide. Despite its significant efficacy in breast cancer, serious side effects may occur with long-term or high-dose use. One of these side effects is tamoxifen retinopathy (TR). Tamoxifen retinopathy typically presents with bilateral visual impairment, crystalline deposits, and changes in the foveal reflex during fundus examination. Although characteristic features can be observed with multimodal imaging, it may be confused with various retinal pathologies. One of the primary conditions considered in the differential diagnosis of TR is macular telangiectasia type 2 (Mac-Tel 2). In this case presentation, we aim to share the differential diagnosis process of TR and highlight the distinguishing features from Mac-Tel 2 in a female patient who presented with decreased vision, based on the patient’s history, detailed fundoscopic examination findings, and multimodal imaging.
- Open Access
- 1 January 2025
- Published by Kare Publishing in Northern Clinics of Istanbul
- Vol. 12 (6) , 694-699
Evaluation of sociodemographic and clinical characteristics of dermatochalasis patients: A retrospective epidemiologic study in a tertiary care eye clinic
The aim of this study was to evaluate systemic and environmental risk factors, clinical findings and surgical trends in patients admitted to our clinic with the diagnosis of dermatochalasis. Between January and March 2024, 114 patients with upper eyelid dermatochalasis were retrospectively analyzed cross-sectionally. Demographic data, history of systemic disease, surgical history, presenting complaints, tear tests (Schirmer, tear breakup time (TBUT)) and dermatochalasis grades were recorded. In the patient cohort, females constituted 66.66%, with a mean age of 53.08±6.35 years. The predominant complaint was a sensation of heaviness or fatigue in the upper eyelid, as reported by 41.22% of the patients. A substantial 70.17% of the participants presented with at least one systemic illness, with diabetes mellitus, hypertension, thyroid disorders, and rheumatologic diseases being the most common. Symptoms of dry eye were observed in 31.57% of the patients, with an average Schirmer test result of 11.03±3.07 mm and a TBUT of 5.87±1.86 seconds. No significant correlation was found between Schirmer and TBUT values and the severity of dermatochalasis (p>0.05). Among the patients, 37.71% were considering surgery, with 65.11% seeking it for cosmetic reasons and 34.88% for functional purposes. Dermatochalasis is a complex condition associated with functional and systemic effects and aesthetic problems. A history of systemic disease, dry eye symptoms and visual field limitation should be considered in managing the disease. Therefore, a multidisciplinary approach should be adopted, and patient expectations should be considered in treatment planning. Prospective studies with a large sample size may better elucidate the etiopathogenesis and patient management.
- 1 January 2025
- Published by Kare Publishing in Northern Clinics of Istanbul
- Vol. 12 (6) , 694-699
Open AccessEvaluation of sociodemographic and clinical characteristics of dermatochalasis patients: A retrospective epidemiologic study in a tertiary care eye clinic
The aim of this study was to evaluate systemic and environmental risk factors, clinical findings and surgical trends in patients admitted to our clinic with the diagnosis of dermatochalasis. Between January and March 2024, 114 patients with upper eyelid dermatochalasis were retrospectively analyzed cross-sectionally. Demographic data, history of systemic disease, surgical history, presenting complaints, tear tests (Schirmer, tear breakup time (TBUT)) and dermatochalasis grades were recorded. In the patient cohort, females constituted 66.66%, with a mean age of 53.08±6.35 years. The predominant complaint was a sensation of heaviness or fatigue in the upper eyelid, as reported by 41.22% of the patients. A substantial 70.17% of the participants presented with at least one systemic illness, with diabetes mellitus, hypertension, thyroid disorders, and rheumatologic diseases being the most common. Symptoms of dry eye were observed in 31.57% of the patients, with an average Schirmer test result of 11.03±3.07 mm and a TBUT of 5.87±1.86 seconds. No significant correlation was found between Schirmer and TBUT values and the severity of dermatochalasis (p>0.05). Among the patients, 37.71% were considering surgery, with 65.11% seeking it for cosmetic reasons and 34.88% for functional purposes. Dermatochalasis is a complex condition associated with functional and systemic effects and aesthetic problems. A history of systemic disease, dry eye symptoms and visual field limitation should be considered in managing the disease. Therefore, a multidisciplinary approach should be adopted, and patient expectations should be considered in treatment planning. Prospective studies with a large sample size may better elucidate the etiopathogenesis and patient management.